The Tencent and Baidu-backed livestreaming app saw its shares almost triple on the first day of trading and is now valued at about $160bn.

The corporate-backed genetic testing service is joining forces with an NYSE-listed special purpose acquisition company sponsored by Virgin Group.

The Alphabet-backed immunotherapy developer secured nearly $588m in what was reputedly the largest ever flotation for a preclinical life sciences company.

The Ping An and SIG-backed cross-border payment services provider will list on the Nasdaq Capital Market through the merger with FTAC Olympus Acquisition Corp.

Harvard-linked Sana brought in nearly four times as much in proceeds as originally planned and saw shares surge 40% on the first day of trading.

Virginia Tech spinout Landos Biopharma priced its shares at $16 to raise $100m and will use proceeds to advance the development of two treatments for inflammatory bowel disease.

Airbus Ventures-backed space launch services provider Astra will get a listing on the Nasdaq Capital Market through the deal.

HY Energy and Yake Food-backed starch sugar additive manufacturer Zhejiang Huakang Pharmaceutical is set to go public in Shanghai.

Chishima Real Estate, M3, Miraca, Nippon Life, POC Clinical Research, Reprocell, Toho Holdings and Zenoaq have all scored exits after the cell therapy provider went public.

Dell Technologies Capital and Hearst Ventures are backing a PIPE investment as the SK Holdings, Avis Budget, NTT Docomo and Delphi-backed vehicle data provider looks to list on Nasdaq.